Position in BBNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,130,621
+$407,658 QoQ
Shares Held
72,152
0.0% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#42
of 133 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $543,574,221 across 18 Medical Devices names. BBNX ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
947,115 | $85,941,215 | |
| 2 | SYK |
Stryker Corp
|
268,461 | $84,522,261 | |
| 3 | MDT |
Medtronic plc
|
994,233 | $77,778,847 | |
| 4 | EW |
Edwards Lifesciences Corp
|
739,234 | $66,871,107 | |
| 5 | DXCM |
Dexcom Inc
|
822,489 | $55,394,634 | |
| 6 | BSX |
Boston Scientific Corp
|
887,650 | $37,884,902 | |
| 7 | STE |
STERIS plc
|
99,877 | $21,031,099 | |
| 8 | PODD |
Insulet Corp
|
127,498 | $19,411,570 |
All Filings in BBNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130,621 | 72,152 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $722,963 | 72,152 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,202,523 | 72,285 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,277,303 | 64,283 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $972,972 | 66,825 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $817,938 | 66,825 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||